Zeto

Zeto is a commercial-stage digital health company providing a disruptive, portable EEG solution that addresses critical access and workflow challenges in neurology diagnostics. Its core product is a wireless, dry-electrode headset that enables rapid, full-montage EEG recordings outside traditional EEG labs, supported by a cloud platform for remote monitoring and an AI algorithm for seizure detection. The company is primarily targeting hospitals, especially in emergency, ICU, and rural settings, to reduce patient transfers and improve timely diagnosis of neurological conditions like seizures and status epilepticus. With over 200 U.S. healthcare facility customers and a growing research pipeline, Zeto is positioned at the intersection of medical devices, neuroscience, and AI-driven digital health.

Wireless, dry-electrode EEG headset integrated with a cloud-based platform for remote monitoring and AI-powered seizure detection (NeuroPulse).

Zeto competes in the portable EEG market against other dry-electrode startups (e.g., Ceribell with its rapid-response seizure detection device) and traditional EEG manufacturers (e.g., Natus, Nihon Kohden) offering more mobile versions of their systems. A key differentiator is Zeto's focus on full-montage, clinical-grade EEG combined with a comprehensive remote monitoring platform, positioning it against limited-channel 'brain monitor' devices used for specific applications.